ABSTRACT
The data in Table 13.2 arise from a clinical trial reported in Thall and Vail (1990). Here 59 patients with epilepsy were randomized to receive either the antiepileptic drug progabide or a placebo in addition to standard chemotherapy. The number of seizures was counted over four 2-week periods. In addition, a baseline seizure rate was recorded for each patient, based on the 8-week pre-randomization seizure count.
